CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Eagle Pharmaceuticals, Inc.  (EGRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

EGRX's Revenue Year on Year Growth by Quarter and Year

Eagle Pharmaceuticals,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
EGRX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 81.14 18.18 -57.92
III Quarter September - 37.83 5.74 5.79
II Quarter June - 40.92 6.00 5.00
I Quarter March 76.79 29.59 36.31 0.00
FY   76.79 189.48 66.23 -47.13

Financial Statements
Eagle Pharmaceuticals,'s first quarter 2017 Revenue $ 76.79 millions EGRX's Income Statement
Eagle Pharmaceuticals,'s first quarter 2016 Revenue $ 29.59 millions Quarterly EGRX's Income Statement
EGRX's Growth by Division See EGRX's Growth by Segment

EGRX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 346.31 % - -
III Quarter September - 559.06 % -0.86 % -
II Quarter June - 582 % 20 % -
I Quarter March 159.52 % -18.51 % - -
FY   - 186.09 % - -



EGRX Revenue Growth Comment
Eagle Pharmaceuticals, Inc. reported Revenue surge of 159.52% year on year in the first quarter, to $ 76.79 millions, this is lower than Eagle Pharmaceuticals, Inc.'s recent average Revenue surge of 322.54%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Revenue growth. While Eagle Pharmaceuticals, Inc.' s Revenue doubling of 159.52% ranks overall at the positon no. 168 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #40
Overall #168
Revenue Y/Y Growth Statistics
High Average Low
625.49 % 322.54 % -18.5 %
(Mar 31 2015)   (Mar 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EGRX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EGRX's Competitors
Revenue Growth for Eagle Pharmaceuticals,'s Suppliers
Revenue Growth for EGRX's Customers

You may also want to know
EGRX's Annual Growth Rates EGRX's Profitability Ratios EGRX's Asset Turnover Ratio EGRX's Dividend Growth
EGRX's Roe EGRX's Valuation Ratios EGRX's Financial Strength Ratios EGRX's Dividend Payout Ratio
EGRX's Roa EGRX's Inventory Turnover Ratio EGRX's Growth Rates EGRX's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions
American Cryostem Corp  205.95 %$ 205.946 millions
Ionis Pharmaceuticals Inc  199.14 %$ 199.138 millions
Immune Design Corp.  193.34 %$ 193.344 millions
Transgenomic Inc  178.81 %$ 178.814 millions
Icu Medical Inc  175.71 %$ 175.710 millions
Novocure Ltd  167.22 %$ 167.218 millions
Invitae Corp  161.39 %$ 161.391 millions
Eagle Pharmaceuticals, Inc.  159.51 %$ 159.515 millions
Alnylam Pharmaceuticals, Inc.  158.13 %$ 158.135 millions
Catasys, Inc.  150.27 %$ 150.275 millions
Catalyst Biosciences, Inc.  148.62 %$ 148.624 millions
Viveve Medical, Inc.  136.84 %$ 136.838 millions
Flex Pharma, Inc.  134.72 %$ 134.724 millions
China Longyi Group International Holdings Ltd  126.39 %$ 126.388 millions
Neos Therapeutics, Inc.  117.85 %$ 117.847 millions
Hemispherx Biopharma Inc  115.38 %$ 115.385 millions
Novabay Pharmaceuticals, Inc.  115.30 %$ 115.300 millions
Aveo Pharmaceuticals Inc  110.47 %$ 110.474 millions
Egalet Corp  103.79 %$ 103.793 millions
China Yct International Group, Inc.  102.56 %$ 102.562 millions
Delcath Systems, Inc.  100.81 %$ 100.811 millions
Green Meadow Products, Inc.  100.00 %$ 100.000 millions
Uluru Inc.  99.57 %$ 99.571 millions
Juno Therapeutics, Inc.  97.72 %$ 97.719 millions
Biocryst Pharmaceuticals Inc  95.79 %$ 95.788 millions